Hyperpolarized Xenon-129 MR Imaging of the Lung — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hyperpolarized Xenon-129 MR Imaging of the Lung — Stella

Recruiting

Back to E-Cig Use trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Snyder Building 480 Ray C. Hunt Drive, Charlottesville, Virginia

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of Virginia

Collaborators

Duke University

Enrollment target

~24 participants

Started

November 2020

Primary completion

December 2022

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated December 2020

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov